Continuous Glucose Monitoring Devices Market Report 2026

Continuous Glucose Monitoring Devices Market Overview

• Continuous Glucose Monitoring Devices market size has reached to $9.79 billion in 2025 • Expected to grow to $21.13 billion in 2030 at a compound annual growth rate (CAGR) of 16.6% • Growth Driver: Increasing Prevalence Of Diabetes Driving Growth In The Continuous Glucose Monitoring Devices Market • Market Trend: Innovative Technologies Driving Growth In The Continuous Glucose Monitoring Devices Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Continuous Glucose Monitoring Devices Market?

Continuous glucose monitoring (CGM) devices track blood sugar levels in real time via a sensor under the skin. They provide continuous data, trend insights, and alerts for highs and lows, helping manage diabetes effectively. These devices reduce the need for frequent finger pricks and enhance glucose control. The main types of components in continuous glucose monitoring devices are transmitters, sensors, and receivers. Transmitters in continuous glucose monitoring devices are components that send glucose level data from the sensor to the receiver or connected device for monitoring. It is getting connectivity through Bluetooth and 4G technology. It is widely used across different demographics, including both the child and adult populations. It is used for various applications, such as gestational diabetes, type-1 diabetes, and type-2 diabetes, and is used by several end users, including hospitals, homecare settings, and other end users.

What Is The Continuous Glucose Monitoring Devices Market Growth Forecast?

The continuous glucose monitoring devices market size is expected to see rapid growth in the next few years. It will grow to $21.13 billion in 2030 at a compound annual growth rate (CAGR) of 16.6%. The growth in the forecast period can be attributed to increasing demand for interoperable diabetes devices, rising investments in ai-driven glucose prediction, expansion of remote diabetes care models, growing focus on data-driven treatment optimization, increasing adoption of next-generation sensor materials. Major trends in the forecast period include increasing adoption of non-invasive cgm technologies, rising demand for cloud-connected glucose monitoring, growing integration of predictive glucose analytics, expansion of long-wear sensor solutions, enhanced focus on user-friendly device design.

Global Continuous Glucose Monitoring Devices Market Segmentation

1) By Component: Transmitters, Sensors, Receivers 2) By Connectivity: Bluetooth, 4G 3) By Demography: Child Population, Adult Population 4) By Application: Gestational Diabetes, Type-2 Diabetes, Type-1 Diabetes 5) By End-Use: Hospitals, Homecare Settings, Other End Users Subsegments: 1) By Transmitters: Bluetooth-Enabled Transmitters, Wireless Transmitters, Integrated Transmitter-Receiver Systems 2) By Sensors: Enzyme-Based Sensors, Electrochemical Sensors, Non-Invasive Sensors 3) By Receivers: Mobile Device Integration (Smartphone Receivers), Standalone Receivers, Cloud-Based Data Sync Receivers

What Is The Driver Of The Continuous Glucose Monitoring Devices Market?

The increasing prevalence of diabetes is expected to propel the growth of the continuous glucose monitoring devices market going forward. Diabetes is a condition where the body is unable to properly regulate blood sugar levels, either due to insufficient insulin production or insulin resistance. The rise in diabetes is largely due to factors like poor diet, sedentary lifestyles, obesity, aging populations, and genetic predisposition. Continuous glucose monitoring (CGM) devices help manage diabetes by providing real-time data on blood glucose levels, enabling timely adjustments to treatment and lifestyle. For instance, in March 2024, according to the Office for Health Improvement & Disparities, a UK-based government department, between March 2022 and March 2023, the percentage of individuals with type 1 diabetes receiving all eight recommended care processes increased by 22%, and for type 2 diabetes, it increased by 21%, while the percentage achieving target HbA1c levels rose to 37.9%, the highest value ever reported by the National Diabetes Audit (NDA). Therefore, the increasing prevalence of diabetes is driving the growth of the continuous glucose monitoring devices industry.

Key Players In The Global Continuous Glucose Monitoring Devices Market

Major companies operating in the continuous glucose monitoring devices market are Johnson & Johnson, F. Hoffmann-La Roche AG, Sanofi S.A., Abbott Laboratories, Medtronic Public Limited Company, Novo Nordisk A/S, Becton Dickinson and Company, A. Menarini Diagnostics S.r.l., Dexcom Inc., Bionime Corporation, Insulet Corporation, Ascensia Diabetes Care Holdings AG, Tandem Diabetes Care Inc., i-Sens Inc., Senseonics Holdings Inc., Medtrum Technologies Inc., Biolinq Inc., GlySens Incorporated, Glucotrack Inc., Nemaura Medical Inc.

Global Continuous Glucose Monitoring Devices Market Trends and Insights

Major companies are operating in the continuous glucose monitoring devices market, focusing on developing innovative technologies, such as over-the-counter continuous glucose monitors, to enhance accessibility, accuracy, and ease of use for users in managing blood glucose levels. An over-the-counter continuous glucose monitor is a device that allows individuals to track their blood glucose levels continuously without needing a prescription. For instance, in September 2024, Abbott Laboratories, a US-based medical device company, launched a Lingo continuous glucose monitoring (CGM) system designed to provide users with real-time glucose data. The device offers real-time, continuous glucose monitoring, providing users with instant feedback on their blood sugar levels throughout the day. It features a sleek, user-friendly design with easy-to-read displays and integrates seamlessly with mobile apps for tracking trends and receiving alerts.

What Are Latest Mergers And Acquisitions In The Continuous Glucose Monitoring Devices Market?

In September 2023, Abbott Laboratories, a US-based medical device company, acquired Bigfoot Biomedical Inc. for an undisclosed amount. With this acquisition, Abbott Laboratories aims to enhance diabetes care by integrating Bigfoot Biomedical's smart insulin management systems with its Freestyle Libre technology. Bigfoot Biomedical Inc. is a US-based medical technology company that provides technologies that integrate with continuous glucose monitoring (CGM) devices.

Regional Outlook

North America was the largest region in the continuous glucose monitoring devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Continuous Glucose Monitoring Devices Market?

The continuous glucose monitoring (CGM) devices include revenues earned by entities by providing services such as real-time glucose monitoring, data sharing, trend analysis, and high or low alerts. The market value includes the value of related goods sold by the service provider or included within the service offering. The continuous glucose monitoring (CGM) devices market also consists of sales of products including dexcom, freestyle libre, medtronic, and eversense. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.